Immune-related Adverse Events in Patients With Cancer Receiving Influenza Vaccination and Immune Checkpoint Inhibitors Reply

被引：0
|
作者：
Chong, Curtis R. [1 ]
Cohen, Bevin [2 ]
Kamboj, Mini [3 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Gastrointestinal Oncol Serv, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Off Nursing Res, 1275 York Ave, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, 1275 York Ave, New York, NY 10021 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2020年 / 70卷 / 07期
关键词：
D O I：
10.1093/cid/ciz518
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
下载
收藏
页码：1519 / 1520
页数：3
相关论文
共 50 条
  • [31] Oral manifestations of immune-related adverse events in cancer patients treated with immune checkpoint inhibitors
    Klein, Brittany A.
    Alves, Fabio Abreu
    de Santana Rodrigues Velho, Julia
    Vacharotayangul, Piamkamon
    Hanna, Glenn J.
    LeBoeuf, Nicole R.
    Shazib, Muhammad Ali
    Villa, Alessandro
    Woo, Sook-Bin
    Sroussi, Herve
    Sonis, Stephen
    Treister, Nathaniel S.
    ORAL DISEASES, 2022, 28 (01) : 9 - 22
  • [32] Mechanisms Driving Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors
    Lee, David J.
    Lee, Howard J., Jr.
    Farmer, Jocelyn R.
    Reynolds, Kerry L.
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (08)
  • [33] Evaluation of immune checkpoint inhibitors rechallenge after immune-related adverse events in patients with cancer
    Tang, X-R.
    Li, R.
    Zhao, F.
    Wen, X.
    Wang, Y-K.
    Lv, R-X.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1269 - S1269
  • [34] Mechanisms Driving Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors
    David J. Lee
    Howard J. Lee
    Jocelyn R. Farmer
    Kerry L. Reynolds
    Current Cardiology Reports, 2021, 23
  • [35] Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer
    Simonaggio, Audrey
    Michot, Jean Marie
    Voisin, Anne Laure
    Le Pavec, Jerome
    Collins, Michael
    Lallart, Audrey
    Cengizalp, Geoffray
    Vozy, Aurore
    Laparra, Ariane
    Varga, Andrea
    Hollebecque, Antoine
    Champiat, Stephane
    Marabelle, Aurelien
    Massard, Christophe
    Lambotte, Olivier
    JAMA ONCOLOGY, 2019, 5 (09) : 1310 - 1317
  • [36] The impact of COVID-19 mRNA vaccines on immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors
    Guo, Mengni
    Ahmed, Zohaib
    Phuong Nguyen
    Zaidi, Kashaf
    Itzkowitz, Raphael
    Chong, Esther G.
    Castillo, Dani Ran
    Huynh Le Cao
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] Cutaneous immune-related adverse events among Taiwanese cancer patients receiving immune checkpoint inhibitors link to a survival benefit
    Cho, Yung-Tsu
    Lin, Yi-Tsz
    Yang, Che-Wen
    Chu, Chia-Yu
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [38] Cutaneous immune-related adverse events among Taiwanese cancer patients receiving immune checkpoint inhibitors link to a survival benefit
    Yung-Tsu Cho
    Yi-Tsz Lin
    Che-Wen Yang
    Chia-Yu Chu
    Scientific Reports, 12
  • [39] Cutaneous immune-related adverse events to checkpoint inhibitors
    Malviya, Neeta
    Tattersall, Ian W.
    Leventhal, Jonathan
    Allon, Allireza
    CLINICS IN DERMATOLOGY, 2020, 38 (06) : 660 - 678
  • [40] Mechanisms of immune-related adverse events during the treatment of cancer with immune checkpoint inhibitors
    Weinmann, Sophia C.
    Pisetsky, David S.
    RHEUMATOLOGY, 2019, 58 : 59 - 67
12345